A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital

BackgroundIn Colombia, the characteristics of cardiac amyloidosis (CA)—including wild-type transthyretin amyloidosis (ATTRwt), immunoglobulin light chain amyloidosis (AL), and genetic variant transthyretin amyloidosis (ATTRv)—are underexplored.MethodsThis case series at a Colombian university hospit...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan David López-Ponce de León, Santiago Granados-Álvarez, Juan Pablo Arango-Ibanez, Juan Manuel Montero Echeverri, Andrea Alejandra Arteaga Tobar, Andrea Facio-Lince Garcia, Yorlany Rodas Cortes, Juan Esteban Gómez-Mesa
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1487717/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548176091938816
author Juan David López-Ponce de León
Juan David López-Ponce de León
Juan David López-Ponce de León
Santiago Granados-Álvarez
Juan Pablo Arango-Ibanez
Juan Pablo Arango-Ibanez
Juan Manuel Montero Echeverri
Andrea Alejandra Arteaga Tobar
Andrea Facio-Lince Garcia
Yorlany Rodas Cortes
Juan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
author_facet Juan David López-Ponce de León
Juan David López-Ponce de León
Juan David López-Ponce de León
Santiago Granados-Álvarez
Juan Pablo Arango-Ibanez
Juan Pablo Arango-Ibanez
Juan Manuel Montero Echeverri
Andrea Alejandra Arteaga Tobar
Andrea Facio-Lince Garcia
Yorlany Rodas Cortes
Juan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
author_sort Juan David López-Ponce de León
collection DOAJ
description BackgroundIn Colombia, the characteristics of cardiac amyloidosis (CA)—including wild-type transthyretin amyloidosis (ATTRwt), immunoglobulin light chain amyloidosis (AL), and genetic variant transthyretin amyloidosis (ATTRv)—are underexplored.MethodsThis case series at a Colombian university hospital analyzed demographic, clinical, laboratory, radiological, and genetic data of CA patients diagnosed between 2018 and 2022. Patients with incomplete data underwent further testing.ResultsOf 24 identified patients, 14 were included after exclusions. The majority were male (73.3%), with an average age of 70.6 years. ATTRv and AL were equally prevalent (42.8%), followed by ATTRwt (14.2%). The p.Val142Ile TTR mutation was found among all ATTRv patients. Most presented with functional capacity NYHA I-II and common electrocardiographic findings included low voltage, atrial fibrillation, and first-degree AV block. Echocardiography and cardiac magnetic resonance imaging revealed ventricular hypertrophy, diastolic dysfunction, reduced longitudinal strain, and late myocardial enhancement.ConclusionsAL and ATTRv were the most common causes of CA followed by ATTRwt. This distribution, along with the clinical, and radiological characterization is consistent with previous reports of other regions. The p.Val142Ile mutation was the only one found in patients with ATTRv, suggesting a strong African genetic influence. These findings enhance our understanding of CA in the region.
format Article
id doaj-art-2786447164ba4f328d2c3db8163361fd
institution Kabale University
issn 2297-055X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-2786447164ba4f328d2c3db8163361fd2025-02-03T06:33:45ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-02-011210.3389/fcvm.2025.14877171487717A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospitalJuan David López-Ponce de León0Juan David López-Ponce de León1Juan David López-Ponce de León2Santiago Granados-Álvarez3Juan Pablo Arango-Ibanez4Juan Pablo Arango-Ibanez5Juan Manuel Montero Echeverri6Andrea Alejandra Arteaga Tobar7Andrea Facio-Lince Garcia8Yorlany Rodas Cortes9Juan Esteban Gómez-Mesa10Juan Esteban Gómez-Mesa11Juan Esteban Gómez-Mesa12Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, ColombiaDepartamento de Cardiología, Fundación Valle del Lili, Cali, ColombiaFacultad de Ciencias de la Salud, Universidad Icesi, Cali, ColombiaFacultad de Ciencias de la Salud, Universidad Icesi, Cali, ColombiaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, ColombiaFacultad de Ciencias de la Salud, Universidad Icesi, Cali, ColombiaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, ColombiaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, ColombiaFacultad de Ciencias de la Salud, Universidad Icesi, Cali, ColombiaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, ColombiaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, ColombiaDepartamento de Cardiología, Fundación Valle del Lili, Cali, ColombiaFacultad de Ciencias de la Salud, Universidad Icesi, Cali, ColombiaBackgroundIn Colombia, the characteristics of cardiac amyloidosis (CA)—including wild-type transthyretin amyloidosis (ATTRwt), immunoglobulin light chain amyloidosis (AL), and genetic variant transthyretin amyloidosis (ATTRv)—are underexplored.MethodsThis case series at a Colombian university hospital analyzed demographic, clinical, laboratory, radiological, and genetic data of CA patients diagnosed between 2018 and 2022. Patients with incomplete data underwent further testing.ResultsOf 24 identified patients, 14 were included after exclusions. The majority were male (73.3%), with an average age of 70.6 years. ATTRv and AL were equally prevalent (42.8%), followed by ATTRwt (14.2%). The p.Val142Ile TTR mutation was found among all ATTRv patients. Most presented with functional capacity NYHA I-II and common electrocardiographic findings included low voltage, atrial fibrillation, and first-degree AV block. Echocardiography and cardiac magnetic resonance imaging revealed ventricular hypertrophy, diastolic dysfunction, reduced longitudinal strain, and late myocardial enhancement.ConclusionsAL and ATTRv were the most common causes of CA followed by ATTRwt. This distribution, along with the clinical, and radiological characterization is consistent with previous reports of other regions. The p.Val142Ile mutation was the only one found in patients with ATTRv, suggesting a strong African genetic influence. These findings enhance our understanding of CA in the region.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1487717/fullamyloidosisAL amyloidosiscardiac amyloidosisColombiaLatin Americatransthyretin
spellingShingle Juan David López-Ponce de León
Juan David López-Ponce de León
Juan David López-Ponce de León
Santiago Granados-Álvarez
Juan Pablo Arango-Ibanez
Juan Pablo Arango-Ibanez
Juan Manuel Montero Echeverri
Andrea Alejandra Arteaga Tobar
Andrea Facio-Lince Garcia
Yorlany Rodas Cortes
Juan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
Frontiers in Cardiovascular Medicine
amyloidosis
AL amyloidosis
cardiac amyloidosis
Colombia
Latin America
transthyretin
title A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
title_full A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
title_fullStr A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
title_full_unstemmed A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
title_short A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
title_sort case series of patients with cardiac amyloidosis evaluated at a colombian university hospital
topic amyloidosis
AL amyloidosis
cardiac amyloidosis
Colombia
Latin America
transthyretin
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1487717/full
work_keys_str_mv AT juandavidlopezponcedeleon acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juandavidlopezponcedeleon acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juandavidlopezponcedeleon acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT santiagogranadosalvarez acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanpabloarangoibanez acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanpabloarangoibanez acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanmanuelmonteroecheverri acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT andreaalejandraarteagatobar acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT andreafaciolincegarcia acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT yorlanyrodascortes acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanestebangomezmesa acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanestebangomezmesa acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanestebangomezmesa acaseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juandavidlopezponcedeleon caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juandavidlopezponcedeleon caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juandavidlopezponcedeleon caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT santiagogranadosalvarez caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanpabloarangoibanez caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanpabloarangoibanez caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanmanuelmonteroecheverri caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT andreaalejandraarteagatobar caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT andreafaciolincegarcia caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT yorlanyrodascortes caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanestebangomezmesa caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanestebangomezmesa caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital
AT juanestebangomezmesa caseseriesofpatientswithcardiacamyloidosisevaluatedatacolombianuniversityhospital